Placeholder Banner

BIO Helps Capital Area Food Bank Meet Demand for Food in Wake of COVID-19 Outbreak

Signs on to multi-industry letter urging federal government to provide testing resources to essential workers

April 15, 2020
Media Contact
Connor McKoy

The Biotechnology Innovation Organization (BIO) is donating $10,000 to the Capital Area Food Bank to help the organization meet the increased demand for healthy and fresh food in the Washington, D.C. community due to the coronavirus outbreak.

“As our community continues to work together to protect against the coronavirus outbreak, we must ensure no one goes hungry,” said BIO’s President and CEO Jim Greenwood. “BIO is extremely grateful for the work the Capital Area Food Bank does for the DMV throughout the year, and especially in this challenging time. We hope this donation helps in meeting the increased demand for food in our communities.”

While the U.S. food supply is strong and safe, protecting the essential workers who put their own health at risk so that families don’t go hungry should be a priority. This includes farmers, government inspectors, food packers, truck drivers, grocery store workers, pantry volunteers, and millions of others. For this reason, BIO has also joined a growing list of industry groups across sectors in a letter to Vice President Mike Pence urging the federal government “to provide COVID-19 testing resources to U.S. employers that are engaged in essential business.”

Without proper testing these employees may unknowingly spread the disease to their co-workers and the public, diminishing any progress made in flattening the curve.

To read the multi-industry letter, click here.

For more information about the Capital Area Food Bank, visit

Discover More
The U.S. Department of Agriculture (USDA) released today a modernized, science-based regulatory system for plant biotechnology aimed at maintaining oversight while driving innovation. Now government and industry must do more to build an informed and…
Immunologist Michelle McMurry-Heath is Selected  for Her Global Leadership and Commitment to Innovation and Patients Former FDA Official Will…
Following the announcement that Dr. Moncef Slaoui will lead the Trump Administration's "Operation Warp Speed" initiative, BIO’s President and CEO, Jim Greenwood, issued the following statement:  “Dr. Moncef Slaoui is an excellent choice…